Towards Personalized MS Therapy: microRNAs as Early Indicators of Cladribine Response
New data presented at the Annual Meeting of the European Charcot Foundation show that circulating miRNAs represent promising mechanism-based biomarkers with the potential to enable more personalized monitoring and refinement of therapeutic strategies in multiple sclerosis.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
